Reverse cholesterol transport--a review of the process and its clinical implications.

Keywords

Reverse cholesterol transport, Cholesterylester transfer protein, Cholesterol, ABCA1, Internal medicine

References

• Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein幸平 林 — 1993
• Increased cholesteryl ester transfer activity in plasma from analbuminemic patients.真規 木村, 秀樹 山内, 政登 鈴木 — 1996
• Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family.Johan Auwerx, Stephan P. Babirak, John E. Hokanson — 1990
• The Metabolic basis of inherited diseaseCharles R.scriver — 1989
• Inhibition of the cellular secretion of cholesteryl ester transfer protein by a variant protein formed by alternative splicing of mRNA.Elaine Quinet, Teresa Yang, C. Marinos — 1993
• Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA.Xian‐Cheng Jiang, Philippe Moulin, Elaine Quinet — 1991
• Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization.John F. Oram, Clare Johnson, Thomas A. Brown — 1987
• Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma.C B Hesler, Alan R. Tall, T L Swenson — 1988
• Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice.S J Busch, Roger L. Barnhart, Gary A. Martin — 1994
• Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases.Alain Barrans, Xavier Collet, Ronald Barbaras — 1994
• Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesteO. L. Francone, Arzu R. Gürakar, C J Fielding — 1989
• The CCAAT/enhancer-binding protein trans-activates the human cholesteryl ester transfer protein gene promoter.Luis B. Agellon, P. Zhang, Xian‐Cheng Jiang — 1992
• Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting.Debra Graham, John F. Oram — 1987
• A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression.P. Knudsen, Marjatta Antikainen, Sonja Ehnholm — 1996
• Libyan family with hypercholesterolemia and increased high-density lipoprotein cholesterol in plasma.Dhastagir Sultan Sheriff, Milad Fakhri, K. Ghwarsha — 1994
• Increased Lipid Transfer Activities in Hyperlipidemic Rabbit PlasmaYonghae Son, D.B. Zilversmit — 1986
• Molecular physiology of reverse cholesterol transport.C J Fielding, P E Fielding — 1995
• Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.Shaobin Zhong, Ira J. Goldberg, Can Bruce — 1994
• Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies.Laurent Lagrost — 1994
• Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins.Jianglin Fan, Jian Wang, A Bensadoun — 1994

Cited by

• Controversy on high density lipoprotein raising therapy.M Cucuianu, Ioana Brudaşcă — 2010
• Apolipoprotein A-I: Insights from Redox Proteomics for its Role in Neurodegeneration蘇雅珍 — 2013
• High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?Olga Stein, Y. Dabach, G. Hollander — 1999
• Arachidonate Remodeling and InflammationAlfred N. Fonteh, Robert L. Wykle — 2012
• DOXORUBICIN-INDUCED, TNF-α-MEDIATED BRAIN OXIDATIVE STRESS, NEUROCHEMICAL ALTERATIONS, AND COGNITIVE DECLINE: INSIGHTS INTO MECHANISMS OF CHEMOTHERAPY INDUCED COGNITIVE IMPAIRMENT AND ITS PREVENTIONJeriel T. R. Keeney — 2013
• Measuring insulin sensitivity and the effect of alternative dietary interventions and exercise on metabolic controlTpj Solomon — 2007
• Genetic Variation of Apolipoprotein B in the Finns: Effects of Serum Lipid LevelsMarja Ilmonen — 2000
• Cholesterol Binding Activity of ApoAI Mimetic Peptide L4FSayali S Onkar — 2013
• Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport.Zhongyan Zhang, Shizuya Yamashita, Ken‐ichi Hirano — 2001
• The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAsDiana M DiMarco, María Luz Fernández — 2015
• Potential peptides in atherosclerosis therapy.Sylvie Marleau, Katia Mellal, David Huynh — 2014
• A common mutation in cholesteryl ester transfer protein gene and plasma HDL cholesterol level before and after hormone replacement therapy in Korean postmenopausal womenKi Ok Han, Chang Hoon Yim, Ho Yeon Jung — 2002
• Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic RetinopathyRoxanne Crosby‐Nwaobi, Irini Chatziralli, Theodoros Ν. Sergentanis — 2015
• Cholesterol in T cells : homeostasis, plasma membrane organization and signalingSaleemulla Mahammad — 2010
• Therapeutic Implications of Thymoquinone in the Management of Diabetes mellitus and its ComplicationsSamir A. E. Bashandy, Gehad A. Abdel Jaleel, Heba M. I. Abdallah — 2015
• Triglycerides and Coronary Heart Disease: Implications of Recent Clinical TrialsHanna Bloomfield Rubins — 2000
• Atherogenesis and its relationship to coronary risk factors.John C. LaRosa — 1998
• The mechanism underlying the hypocholesterolaemic activity of aqueous celery extract, its butanol and aqueous fractions in genetically hypercholesterolaemic RICO rats.Daniel Tsi, Benny K.H. Tan — 2000
• Expression of scavenger receptor class B1 in endometrium and endometriosis.Sumathi Ramachandran, Mingqing Song, Ana A. Murphy — 2001
• Low high-density lipoprotein cholesterol disorders and cardiovascular risk: contribution of associated low-density lipoprotein subclass abnormalitiesRobert S. Rosenson — 2005

Related papers

• Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.Yasushi Nakamura, L Kotite, Yonghong Gan — 2004
• High-Density Lipoprotein-Targeted Therapy and Apolipoprotein A-I Mimetic Peptides.Yoshinari Uehara, Giulia Chiesa, Keijiro Saku — 2015
• Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease.H. Bryan Brewer, Alan T. Remaley, Edward B. Neufeld — 2004
• LecithinHiroyuki Tanigawa, Jeffrey T. Billheimer, Junichiro Tohyama — 2009
• The role of phospholipid transfer protein and cholesteryl ester transfer protein in reverse cholesterol transportRiikka Vikstedt — 2009
• Serum Opacity Factor Enhances HDL-Mediated Cholesterol Efflux, Esterification and Anti Inflammatory EffectsUrbain Tchoua, Corina Rosales, Daming Tang — 2010
• Reverse cholesterol transport and future pharmacological approaches to the treatment of atherosclerosis.B R Krause, B J Auerbach — 2001
• Why Targeting HDL Should Work as a Therapeutic Tool, but Hasn’tMary G. Sorci‐Thomas, Michael J. Thomas — 2013
• Novel Cocrystallization of Apolipoprotein A‐I with Butyric AcidGrace Ferri, Xiaohu Mei, David Atkinson — 2021